Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Breunig

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 22, 2008
Nomen est omen. Fabry diseaseF Weidemann, C Wanner, F Breunig
Kidney International|April 13, 2006
Clinical benefit of enzyme replacement therapy in Fabry diseaseF Breunig, F Weidemann, J Strotmann, et al.
Zeitschrift Fur Kardiologie|September 6, 2005
Morbus Fabry of the heart. Why should cardiologists care?J Strotmann, F Weidemann, F Breunig, et al.
Molecular Genetics and Metabolism|October 10, 2008
Enzyme replacement therapy in Fabry disease: towards a better understanding of the implications of antibody formation and doseC E M Hollak, A C Vedder, B Winchester, et al.
Deutsche Medizinische Wochenschrift (1946)|September 8, 2007
[Phenotyping of type 2 diabetes mellitus by "genetic field work": are data sufficient that are based only on a questionnaire?]D Mönks, F Swoboda, F Breunig, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 2011
Right ventricular involvement in patients with Fabry's disease and the effect of enzyme replacement therapyW Wuest, W Machann, F Breunig, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry diseaseB Dietrich, N Karpinski, M Jakob, et al.
Journal of Internal Medicine|April 17, 2013
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complicationsF Weidemann, M Niemann, S Störk, et al.
European Journal of Clinical Investigation|February 9, 2008
Misleading terms in Anderson-Fabry diseaseF Weidemann, J M Strotmann, F Breunig, et al.
Journal of Inherited Metabolic Disease|March 10, 2007
Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry RegistryC M Eng, J Fletcher, W R Wilcox, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 22, 2008
Nomen est omen. Fabry diseaseF Weidemann, C Wanner, F Breunig
Kidney International|April 13, 2006
Clinical benefit of enzyme replacement therapy in Fabry diseaseF Breunig, F Weidemann, J Strotmann, et al.
Zeitschrift Fur Kardiologie|September 6, 2005
Morbus Fabry of the heart. Why should cardiologists care?J Strotmann, F Weidemann, F Breunig, et al.
Molecular Genetics and Metabolism|October 10, 2008
Enzyme replacement therapy in Fabry disease: towards a better understanding of the implications of antibody formation and doseC E M Hollak, A C Vedder, B Winchester, et al.
Deutsche Medizinische Wochenschrift (1946)|September 8, 2007
[Phenotyping of type 2 diabetes mellitus by "genetic field work": are data sufficient that are based only on a questionnaire?]D Mönks, F Swoboda, F Breunig, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 2011
Right ventricular involvement in patients with Fabry's disease and the effect of enzyme replacement therapyW Wuest, W Machann, F Breunig, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry diseaseB Dietrich, N Karpinski, M Jakob, et al.
Journal of Internal Medicine|April 17, 2013
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complicationsF Weidemann, M Niemann, S Störk, et al.
European Journal of Clinical Investigation|February 9, 2008
Misleading terms in Anderson-Fabry diseaseF Weidemann, J M Strotmann, F Breunig, et al.
Journal of Inherited Metabolic Disease|March 10, 2007
Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry RegistryC M Eng, J Fletcher, W R Wilcox, et al.
Pageof 2